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Summary 
Injecting drug users are a major risk group for infection with the human immunodeficiency virus 
and other infectious diseases. Needle exchange programmes are based on a harm reduction 
approach and are designed to meet the needs of injectors who are unable or unwilling to cease 
injecting. The aim of needle exchange programmes is a reduction in the risk behaviours of 
injectors and a subsequent decrease in the incidence and transmission of infectious disease. These 
behaviours include the sharing of injecting equipment and unsafe sexual practices. Despite some 
behaviour change a substantial number of injectors continue to share injecting equipment and 
engage in risky sexual practices. This study analyses data from the years 1990-1997. 
The number of injecting drug users who attended the Eastern Health Board needle exchange 
programme increased from 1990-1997, with a recent increase in the proportion of female 
attenders. The number of young injectors is increasing, and a large proportion of attenders are 
under twenty years of age. Almost one third of users have a very short duration of injecting, less 
than one year. 
Decreases in high risk behaviour at first attendance are seen over the time period. Attenders who 
have been injecting less than one year have less needle sharing than those injecting longer. The 
high risk behaviours of needle sharing and not using condoms are significantly related to one 
another.   Female injectors have a significantly higher proportion of needle sharing than their 
male counterparts. 
The young injectors age group show an increase in numbers of attenders over the time period. 
Young males have decreased in number from a peak in 1995 whereas numbers of young females 
have steadily increased. Half of young injectors have been injecting less than one year. Very few 
of the young attenders have had any treatment; needle exchange may be the first contact with 
services for many. 
Young injectors are not significantly different in their proportion of needle sharing than injectors 
age twenty and over. Needle sharing is significantly lower in the recent onset injectors, especially 
those injecting less than one year. 
Young injectors are significantly more likely to use a condom during sexual encounters than the 
overall population of injectors, but young females are significantly less likely to have their 
partners use a condom during sexual encounters than young males. Young injectors with one 
partner are much less likely to use condoms during sex. 
High risk behaviours at first attendance show a. decreasing trend and it appears that prevention 
messages are being heeded, though prevalence of high risk behaviour remains unacceptably high. 
The needle exchange programme is effective at attracting high risk, female and young injecting 
drug users. In Dublin, injectors appear to be coming to needle exchange very soon after initiation 
of injecting. This is very important in terms of the potential for prevention and intervention. 
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Introduction 
Injecting drug users are a major risk group for infection with the human immunodeficiency virus 
(HIV) and other infectious diseases. The estimated prevalence of HIV in the European Union 
adult population aged between 15-59 years is 198 cases per 100, 000. Forty two percent of these 
cases are related to intravenous drug use (1). 
The aim of needle exchange programmes is a reduction in risk behaviours of injectors including 
sharing of injecting equipment and unsafe sexual practices and a subsequent decrease in the 
incidence and transmission of infectious disease. Exchanges are ideally made as accessible as 
possible with none or low thresholds for eligibility, minimal identification requirements and 
informal relationships with staff. The exchange is potentially an important channel to other 
services (2). 
Cities that are characterised by community outreach programmes and good access to sterile 
injecting equipment have successfully prevented HIV epidemics and seroprevalence has remained 
stable and low. In these cities prevention measures were put in place early (1987-1988), before 
any rapid transmission of HIV began (3). Needle exchange is an integral part of the prevention 
strategy for the reduction in transmission of infectious disease and attendance has been shown to 
reduce sharing behaviours (4). 
1.1 Public health concept of harm reduction 
The complex nature of drug addiction has meant that no single intervention measure, whether 
preventive or treatment, is enough to prevent or reduce drug misuse. The harm reduction 
approach is based on the principles of public health. The approach recognises that the goal of 
complete cessation of drug misuse for many drug users is unrealistic in the short term. The goal 
of a reduction in potential harm is a legitimate, pragmatic and humane response to this problem. 
Harm Reduction is based on three basic assumptions (5): 
(a) the approach is an alternative to the moral/criminal and disease model of drug use 
and addiction, and recognises abstinence as an ideal outcome but accepts alternatives 
that reduce harm 
(b) approach is primarily ‘bottom up’, based on client advocacy 
(c) there is low threshold for access. 
Needle exchange programmes seek to reduce injection related harm in drug users by the reliable 
and consistent access to a hygienic needle supply and by a knowledge and means educational 
approach. This strategy enables behavioural change by providing injecting drug users with 
information about the changes that need to be made, and the means to acquire sterile injecting 
equipment. The provision of a non- 
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judgmental, confidential service encourages the building of a relationship between the health 
services and what is recognised to be a highly marginalised group. Service providers educate, 
encourage and empower injecting drug users to reduce their individual risk and the risks to 
partners, children and the wider community, of contracting and spreading infection. 
1.2 Risk behaviours in drug users 
Brown in a review article of risk behaviours and the transmission of HTV infection concluded 
that needle sharing is the crucial transmission route within the injecting drug using community 
and the sexual transmission route is likely to be the most common route out of the community 
and into the wider population. Needle sharing rates range from 13% to 73% in international 
studies (1). 
1.3 Young injectors 
There are few studies in the international literature specifically concerned with young injectors. 
Fennema (6) in a Dutch cohort study found that a number of young users (under 25 years of age) 
had short injecting histories and had a lower seroprevalence than the whole cohort. Young 
injectors and recent onset injectors were found to be at greater risk of HTV infection than the 
older and longer term users due at least in part to behavioural factors. 
1.4 Injecting drug users in Ireland 
In Ireland, 98% of heroin misusers in treatment are resident in the Eastern Health Board (7). The 
1997 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) report indicates 
that Ireland has the youngest mean age of treated drug use at 23.6 years (1995 figures) and two 
thirds of treated drug users are under the age of 25 years (8). 
The overall number and percentage of young people in the 15 to 19 age group attending for drug 
treatment in the greater Dublin area has increased from 336 (17%) in 1990, to 1170 (29%) in 
1996 (7). The patterns of drug use among teenagers has changed as well and current trends show 
younger opiate users more likely to smoke heroin than inject. 
1.5 Rationale for study 
This study is an analysis of the database from the Eastern Health Board needle exchange 
programme. The analysis will describe the characteristics and behaviours of the injecting drug 
population who use the needle exchange programme in Dublin and identify any trends over time. 
Data on young injectors is analysed as a subset to describe this important sub-group and their 
characteristics. 
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Aims and Objectives 
2.1 Aims 
The aims and objectives of this study are: 
2.1.1 Needle exchange attenders 
Aim 
To analyse the existing database on injecting drug users who attended the Eastern Health 
Board needle exchange programme from 1990-1997. 
Objectives 
To provide a descriptive analysis of injecting drug users who were attenders at the Eastern 
Health Board needle exchange programme from 1990-1997, including describing the 
socio-demographic characteristics, number of years injecting drug use, drug related 
characteristics, and risk behaviours of attenders and to identify trends over time. 
To identify factors associated with high risk behaviours; sharing of injecting equipment, 
lack of condom use, and the number of sexual partners. 
2.1.2 Young injectors 
Aim 
To focus particular attention on young attenders between the ages of 15 and 19 years. 
Objectives 
To provide a descriptive analysis of a subgroup of attenders, young attenders between the 
ages of 15 and 19 years; including describing the socio-demographic characteristics, 
number of years injecting drug use, drug related characteristics, and risk behaviours of 
attenders and to identify trends over time. 
To determine if young injectors have increased needle sharing and high risk sexual 
behaviour. 
Methods 
3.1 Study population 
The study population consists of all injecting drug users who attended the Eastern Health Board 
Needle Exchange Programme from 1990-1997. Data is collected from eleven clinics in the 
greater Dublin area. The first clinic was established mid-year in 1989 and data from this year was 
discarded. All data on first attendance for the years 1990-1997 was used in the analysis. 
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3.2 Information system and database 
The Health Information System was established at the initiation of the needle exchange 
programme. All needle exchange programme sites participate in the system. Data is routinely 
collected at source by outreach workers in the presence of the drug user. Data is collected 
anonymously on all attendees and each is given a unique number. This number is assigned at a 
central location where data from all the clinics is coded and entered into the Health Board’s 
mainframe computer. 
3.2.1 Interviews with staff 
Informal interviews were conducted with three outreach workers (two senior)/ the clerical officer 
responsible for coding and inputting the data and a public health specialist in charge of health 
information systems in the health board. The purpose of these interviews was to determine the 
way in which information was collected and coded from the individual drug users and the clinics 
and progressed through the system. 
3.2.2 Data form content 
The following variables were analysed for this report: socio-demographic data; name/ using only 
first and last initials to preserve anonymity within the data system/ sex/ date of birth. The drug 
behaviour data collected was: number of years of injecting drug use and the number of 
detoxifications and interest in methadone treatment. The following data on risk behaviour in the 
previous year was collected: needle sharing/ number of sexual partners and condom use. The 
following data is also collected on first attendance and on each subsequent attendance; date of 
visit/ needles in (number of needles returned)/ needles out (number of needles supplied)/ and 
were condoms taken. 
3.3 Data analysis 
Data was downloaded from the mainframe health board computer and analysed using the SAS 
institute Jump In® programme and Epi-info 6. Frequency distributions were completed for all 
nominal variables and means/ medians and ranges were computed for continuous variables. To 
test association between variables, Pearson’s chi square tests and Fisher’s Exact test were used for 
univariate comparisons. For assessing trend/ chi square tests for trend were used. 
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Results 
4.1 Overview 
The number of injecting drug users who attended the Eastern Health Board needle exchange 
programme increased from 1990-1997 as is shown in Table 1. 
Table 1. Number of first attenders at needle exchange from 1990-1997 
Year of first attendance Number (percent) 
Year of first attendance Number (percent) 
1990 350 (6%) 
1991 237 (4%) 
1992 590 (10%) 
1993 906 (15%) 
1994 956 (16%) 
1995 1217(20%) 
1996 730 (12%) 
1997 1039 (17%) 
Total 6025 
The total number of attenders is 6025.   Due to missing data or unusable data this denominator 
changes with different variables during the analysis. 
4.1.1 Demographics 
Gender 
New attenders are primarily male (80.11%). Table 2 shows the numbers and proportions of male 
and female first time attenders. The number of attenders has increased for both sexes. The 
proportion of female attenders was stable from 1990-1995 with an increase seen in 1996 and 
1997. This is a statistically significant trend. 
Table 2. First attenders at needle exchange by gender 
Year of first attendance Males Females 
1990 283 (82%) 62 (18%) 
1991 195 (84%) 36 (16%) 
1992 480 (81%) 109(19%) 
1993 735 (81%) 171 (19%) 
1994 780 (182%) 166 (18%) 
1995 987 (81%) 225 (19%) 
1996 494 (76%) 159 (24%) 
1997 698 (76%) 226 (24%) 
Totals 4652 (80%) 1155 (20%) 
x2 tr= 16.85, p-value= .00004 
Age 
The mean age of first attenders is 25.04 years with a median age of 24 years, range 15-58 years. 
Age was categorised into four groups for further analysis; 15-19 years, 20-24, 25-29, 30 and over. 
A large proportion of attenders are young (15-19) and there is a statistically significant 
association between the sex of the injector and which age group they are from, as is shown in 
Table 3. Males predominate but there are proportionately more females in the younger age 
groups. Fifty-seven percent of the population is under 25 years old and 21% are under the age of 
20 years. 
Table 3. Age group of male and female first time attenders 
Age groups: Male Female Number (%) 
15-19 years 923 (75%) 303 (25%) 1226 (21%) 
20-24 1652 (80%) 425 (20%) 2077 (36%) 
25-29 1119 (82%) 247(18%) 1366 (24%) 
30+ 931 (84%) 178 (16%) 1109 (19%) 
Totals 4625 1153 5778 
x2 tr= 30.01, p-value= .00001 
4.1.2 Characteristics of injecting and drug use 
Number of years injecting 
The overall mean number of years of injecting drug use for first time attenders is 4.1 years, see 
Table 4. Males have proportionately longer duration of injecting. Almost one third (29%) of users 
have a very short duration of injecting, less than one year. 
Table 4. Number of years injecting drug use in male and female first time attenders 
Number of years IDU Male Female Total 
<1 year 1283 (28%) 403 (35%) 1686 (29%) 
1-4 1810 (39%) 478 (42%) 2288 (40%) 
5+ 1495 (33%) 259 (23%) 1754 (31%) 
Totals 4588 1140 5728 
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x2tr = 45.26, p=<.0001 
Treatment and Exchange services 
The exchange programme supplies needles and syringes at the first attendance. The mean number 
of needles given out to injecting drug users at first attendance is 4.0. Condoms are also offered 
and 47% took condoms. 
Number of sexual partners 
The mean number of sexual partners in the previous year was 2.55. Males were twice as likely to 
have more than one sexual partner than females. Two thirds of female injectors had one partner in 
the previous year, see Table 5. 
Table 5. Number of sexual partners in the previous year for male and female injectors 
at first attendance 
Number of sexual partners Male Female Number (percent)
None 769 (18%) 211 (19%) 980 (18%) 
One 2110 (48%) 694 (64%) 2804 (51%) 
Multiple (more than one) 1488 (34%) 182 (17%) 1670 (31%) 
Totals 4367 1087 5454 
x2tr = 67.97, p-value=<.0001 
4.1.3 Risk behaviours and related factors 
Risk behaviours reported at first attendance are needle sharing and condom usage in previous 
year. 
Trend over time 
Decreases in high risk behaviour at first attendance are seen over the time period. Figure 1 shows 
the changes in risk behaviour of first time attenders over the 1990-1997 time period. Needle 
sharing has shown a significant decreasing trend (x2tr=24.81, p=<.0001). The use of condoms 
during sexual encounters has shown a significant increasing trend (x2 tr=19.29, p=.00001). 
Figure 1. Percentage of first attenders needle sharing and using condoms 1990-1997 
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 4.1.4 Needle Sharing 
The overall prevalence of needle sharing at first attendance in the previous year is 2020, 39% of 
injectors. 
Needle sharing and gender 
Table 6 illustrates the patterns of high risk behaviour of male and female injectors. Female 
injectors are engaged in more risk taking behaviour compared to males. Female injecting drug 
users have a significantly higher proportion of needle sharing than their male counterparts. The 
prevalence of needle sharing was 38% for males compared with 44% for females. 
Table 6. Needle sharing of male and female injecting drug users. 
 Needle 
Sharing 
Not 
Sharing 
Total 
Male 1568 (38%) 2549 (62%) 4117 
Female 448 (44%) 564   (56%) 1012 
Totals 2016 3113 5129 
x:=13.02, p=.0003 
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Needle sharing and age group 
Needle sharing is greatest in the 20-24 year age group, and is lowest in the 30+ age group. Table 7 
shows that the highest prevalence of needle sharing is occurring in the age group (20-24) with the 
highest number and proportion of attenders. 
Table 7. Needle sharing of first attenders by age group 
Age Group Needle  
Sharing 
Not 
Sharing 
Total 
15-19 424 (39%) 663 (61%) 1087 
20-24 776 (42%) 1051 (58%) 1827 
25-29 480 (39%) 738 (61%) 1218 
30+ 335 (34%) 646 (66%) 981 
Totals 2015 3098 5113 
x2 tr=7.16, p=.0058 
4.1.5 Condom Usage 
Fifty-five percent (2825) of first time attenders report using a condom during sexual encounters in 
the previous year. 
Condom usage and gender 
Table 8 illustrates the patterns of high risk behaviour of male and female injectors. Female 
injectors are engaged in more risk taking behaviour than males. Female injecting drug users are 
less likely to have a condom used by their partner during a sexual encounter than males. 
Table 8. Condom usage of male and female first attenders 
 Condom 
Use 
Lack of 
Condom Use 
Total 
Male 2321 (56%) 1804 (44%) 4125 
Female 503 (49%) 524 (51%) 1027 
Totals 2824 2328 5152 
x2=17.64, p=<.0001 
Condom usage and age group 
Condom usage is significantly related to age group with the younger age groups much more 
likely to report condom use, see Table 9 below. 
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Table 9. Age group and condom usage of first attenders 
Age Group Condom 
Use 
Lack of Condom 
Use 
Total 
15-19 601 (61%) 379 (39%) 980 
20-24 902 (55%) 733 (45%) 1635 
25-29 515 (50%) 507 (50%) 1022 
30+ 405 (53%) 356 (47%) 761 
Totals 2423 1975 4398 
x2tr=17.06, p=.00004 
4.2 Young Injecting Drug Users 15-19 years. 
Overview 
There were 1224 (21%) first time attenders between the ages of 15 and 19 years old. Figure 2 
below shows the age group distribution of young attenders in relation to the overall population. 
The young injectors have an increase in the number of attenders over the time period, and now 
represent the second largest age group. 
Figure 2. Age groups of first time attenders at needle exchange programme 1990- 1997 
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4.2.1 Demographics of young injectors 
Seventy-five percent of the young attenders are male. The overall number of young injecting drug 
users shown in Table 10 has increased over the time period. Young males have decreased in 
number from a peak in 1995 whereas the number of young females has steadily increased from 
1990-1997 to 32% of young first time attenders. The mean age of young injectors is 18.59 years. 
Table 10. Number and gender of Young of attendance 
Year of attendance  Males  Females  
1990 38 (86%) 6 (14%) 
1991 15 (94%) 1 (6%) 
1992 58 (88%) 8 (12%) 
1993 119 (74%) 41 (26%) 
1994 164 (80%) 42 (20%) ,  
1995 216 (79%) 59 (21%) 
1996 138 (68%) 65 (32%) 
1997 169 (68%) 80(32%) 
Totals 917 302 
X2tr= 19-40, p= .00001 
Number of sexual partners 
The mean number of sexual partners in the previous year for young injectors is 3.06 (analysis 
excludes subjects who were not sexually active, i.e. no sexual partners in the previous year), 42% 
have had more then one sexual partner (multiple partners) in the previous year, and there was a 
range of 1-40 partners. The variable “number of sexual partners” was grouped into three 
categories and is shown in Table 11. Females are much more likely to have had only one sexual 
partner in the previous year compared to males. 
Table 11. Number of sexual partners of young injectors 
No. of sexual partners Male Female Total 
None 144 (16%)  55 (19%) 199 (17%) 
One 321 (36%) 172 (58%) 493 (41%) 
Multiple (>1) 428 (48%) 70 (24%)-*• 498 (42%) 
Totals 893 297 1190 
x2tr=30.50, p=<.00001 
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4.2.2 Risk behaviours and related factors for young injectors. 
Overview 
Figure 3 describes the age distribution of risk behaviours. Needle sharing shows a generally 
decreasing trend with a peak prevalence in the 20-24 age groups. Needle sharing is lower in the 
youngest and older age groups (x2tr=7.614, p=.0058). The proportion of injectors reporting 
condom usage decreases with age (x2 tr=17.056, p-.00004). The proportion of injectors with 
multiple sexual partners also decreases with age (x2 tr=148.91, p=<.0001). 
Figure 3. Age group distribution of needle sharing, lack of condom use and sexual partners in 
young injectors 
 
Trend over time 
There has been a decrease in”‘ the risk behaviours of young injectors over the time period 1990-
1997 as is shown in Figure 4. Needle sharing prevalence has fluctuated from year to year but 
there ‘has been a general decrease which is not statistically significant (x2 tr=0.17, p=.68). 
Condom use has increased significantly over the seven years (x2rr=5.21, p=.02). 
Figure 4. Needle sharing and condom usage of young injectors at first attendance 1990-1997 
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 4.2.3 Needle sharing 
Overall prevalence of needle sharing 
Young injectors have a 39% needle sharing prevalence. This is identical to the prevalence in the 
overall population of injecting drug users. 
Needle sharing and number of years injecting 
Table 12 shows that needle sharing is significantly lower in the recent onset injectors, especially 
those injecting less than one year. There is a significant increase in the proportion of needle 
sharing as the length of time injecting increases. 
Table 12. Number of years injecting and needle sharing by young injectors 
Number of years IDU Needle 
Sharing 
Not Needle 
Sharing 
Total 
Under 1 year 166 (34%) 320 (66%) 486 
1-4 years 241 (42%) 329 (58%) 570 
5 + years 14 (61%) 9  (39%) 23 
Totals 421 658 1079 
x2tr=11.11, p=.00086 
Needle sharing and condom usage in young injectors 
Needle sharing and condom usage are significantly associated in young injectors. Table 13 shows 
attenders who do not needle share are more likely to use a condom compared to those who do 
needle share. 
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Table 13. Needle sharing behaviour and condom usage in young injectors 
 Condom Use Lack of Condom Use Totals 
Needle Sharing 185 (51%) 178 (49%) 363 
Not Needle Sharing 392 (68%) 188 (32%) 580 
Totals 577 366 943 
x2 =25.96, p=<.0001 
4.2.4 Condom Usage 
Overall prevalence of condom usage 
Young injectors had a 61% prevalence of using a condom during sexual encounters in the 
previous year. Young injectors’ condom use is significantly higher compared to the overall 
population of injectors (55%), (x2=15.52, p=<.0001). 
Prevalence of condom usage and gender in young injectors 
Differences in risk behaviour for male and female young injectors are described in Table 14. 
Females are significantly less likely to have their partners use a condom during sexual encounters 
Table 14. Condom usage of male and female young injectors 
 Male Female Total 
Lack of Condom use 304 (36%) 130 (48%) 434(39%) 
Condom Use 535 (64%) 141 (52%) 676 (61%) 
Totals 839 271 1110 
x2=11.85, p=.0007 
Number of sexual partners in the previous year and condom usage in young injectors 
Injectors with one partner were compared for high risk behaviours to injectors with multiple 
partners (Table 15). Young injectors with one partner are much less likely to use condoms during 
sex. Injectors with multiple sexual partners are more likely to use condoms. 
Table 15. Number of sexual partners and condom usage of young injectors 
Sexual Partners Condom Use Lack of Condom Use Total 
One 267 (55%) 220 (45%) 487 
Multiple (>1) 334 (68%) 159 (32%) 493 
Totals 601 397 980 
- 20 - 
x2 =17.25, p=<.0001 
Discussion 
5.1 Needle exchange programme 
The analysis of the first attendance data provides evidence of trends in the characteristics of the 
drug using population attending the needle exchange programme in Dublin. The proportional 
increase in young and female users is clearly seen over time. The needle exchange programme is 
effective at attracting high risk, female and young injecting drug users. This is in contrast to what 
is seen in the international literature where needle exchange is often seen as a last option and 
attenders are often older with well established injecting careers. High risk behaviours at first 
attendance show a decreasing trend over the time period, and it appears that prevention messages 
are being heeded, though prevalence of high risk behaviour remains unacceptably high. 
5.1.1 Gender 
This study finds evidence that both the number and proportion of female injectors has increased 
over the eight years of the needle exchange programme, especially in recent years. This change is 
greatest in the younger age groups. This could reflect the change in the wider society of a 
narrowing of the gender gap between men and women. Females have a higher proportion of 
recent onset of injecting, and 35% have been injecting less than one year. Females are engaging in 
more risk behaviours with a significantly higher proportion of needle sharing (44%) compared to 
males (38%). The proportion of females (51%) not using a condom during sexual relationships is 
also higher compared to males (44%). This could be due to the high proportion of females (64%) 
in the present study who had only one sexual partner and appear to be in long term relationships. 
5.1.2 Recent onset of injecting  
In Dublin injectors are ‘ coming to needle exchange soon after the initiation of injecting. This is 
very important in terms of prevention as the longer the length of injecting drug use the greater the 
probability of high risk behaviours. There is evidence in the international literature that 
transmission of infection occurs in the early years of injecting drug use (9). 
5.1.3 High risk behaviour 
Needle sharing is a common occurrence with 39% of injectors reporting needle sharing in the 
previous year. Needle sharing occurrence is generally higher in the younger age groups and 
decreases significantly in those over 30 years of age. Needle sharing is also greater in drug users 
who have been injecting more than one year. Those injecting less than one year are less likely to 
share needles. 
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The use of condoms during sexual encounters is much more common in the young injectors. The 
change in legislation on condom usage in 1993 means that many young injectors would have had 
the benefit of safe sex messages and have a higher awareness of condoms. The older attenders 
may not have yet adapted to wearing condoms, or are in long term relationships and feel they are 
not necessary. Injectors with multiple sexual partners appear to be protecting themselves to a 
greater degree than those with one sexual partner by wearing condoms during sexual encounters. 
5.1.4 Prevention and services 
In relationships where both partners are injecting, attempts to stop or reduce drug use are very 
difficult to maintain if both partners do not remain committed to treatment or abstinence. The 
sexual relationship is a key site for consideration in prevention programmes. Where risks are 
being taken as part of a long term sexual partnership targeting the couple for intervention may be 
more productive. The health services, armed with health promotion’s philosophy of helping 
people to help themselves by making it easier for them to make the safer choice, can foster and 
encourage and use these mechanisms if they recognise them. 
Friedman (10) looked at rates of seroconversion in low (under 8%) and high prevalence (21% or 
higher) cities and suggested that different approaches to prevention need to be considered. In high 
seroprevalence cities, needle sharing is the major risk factor while in low prevalence cities 
infection is spread through ‘pockets of infection’ in socio-behavioural groups that engage in high 
risk behaviours and have high seroprevalence. The 1993 prevalence of HTV in Dublin was 8% 
which by Friedman’s designation makes it a low prevalence city where transmission occurs 
within relatively small social networks. This is consistent with what we know about the Dublin 
injecting drug users, that they come from marginalised areas of the city where poor socio-
economic conditions are the norm. Cycles of poverty and imprisonment reinforce the risks that 
exist in these groups. No prevention programme can be as effective as reducing the numbers of 
individuals who come into drug use in the first place. This is a problem of society and must be 
addressed not only by the health services but in the economic and political spheres. 
5.2 Young Injectors 
The proportion of young injectors, aged 15-19 is 21% of needle exchange first attenders. The 
number and proportion of young injectors has increased steadily from 1990 to 1997. Ireland has a 
young population and this is reflected in the figures. Nevertheless/ 60% of drug users attending 
needle exchange are under 25. This is different from what is found in the international literature, 
where needle exchange attendance is generally associated with older-injecting drug users and 
injectors with long injecting careers. 
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5.2.1 High risk behaviours of young injectors 
The prevalence of needle sharing in young injectors is identical to that of the overall population 
(39%).Condom use was greater in the young injectors, especially males, and those with multiple 
sexual partners. Young injectors with multiple sexual partners are one and a half times as likely to 
needle share. Using a condom during sexual encounters and having a recent onset of injecting 
lowered the odds of needle sharing. Again this is a similar pattern to the overall population. The 
first year of injecting appears to be a very important time in terms of self protection and risk 
reduction. 
5.2.2 Vulnerability of young injectors 
Young users may be at greater risk for prostitution or crime to support drug habits. The income of 
young injectors and their income generating ability is very small. Prostitution by both male and 
female injectors exposes the user to an increased risk of infection with HTV, and sexual and 
physical violence. In addition to the harm prostitution can bring to the injecting drug user it 
provides a bridge for infection to enter the wider community. Income generated by crime exposes 
the drug user to a violent and anti-social way of life, which often ends in imprisonment. Prison 
exposes users to infection through the shared use of equipment and the high prevalence of HIV 
and hepatitis infections. Any infections transmitted in prison are transmitted to contacts outside of 
the prison when release occurs. Drug users’ pattern of imprisonment, short stays but many in 
number, put them at risk for getting and transmitting the virus. 
Experimentation with heroin use, especially smoking heroin, is very much in evidence in popular 
youth culture today. The worlds of music, fashion, literature, and film combined with the 
erroneous belief that smoking heroin is not addictive may lead young people to experiment with 
hard drug use. The peer pressure to conform is stronger in adolescence than in older adulthood. 
There is a romantic notion associated with counter culture and the rebellion of youth, which is 
natural in context. In marginalised areas where real life does not offer up much, the lure of 
fantasy and escapism is strong. 
The outreach workers are seeing an increase of young people who started smoking heroin, 
coming into the needle exchange quite quickly as they have to move on to injecting with its more 
efficient effects. This transition may occur at a time of shortage of the supply of the drug or when 
an individual is short of money. Young people may be initiated into drug injection by other users; 
peers or partners who supply the equipment. Young users may not have the experience or the 
money to organise their personal supply of safe injecting equipment. Young injecting drug users 
are also reported to lend injecting equipment more often than older users. The outreach workers 
describe reported emotions of despair and self loathing by young injectors expressing disbelief at 
the plight they find themselves in. The desperation for the drug alerts them to the nature of their 
addictions as it moves from a recreational smoking habit to a desperate craving and injecting 
problem. Forty-eight 
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percent of the 15-19 year olds who are coming to needle exchange have been injecting less than 
one year (this is the shortest duration we can record). There is some informed anecdotal evidence 
that young users are presenting to needle exchange very quickly after their first injection. 
Young injectors are aware of the risks of sharing needles and are concerned to protect themselves. 
This situation is a tremendous opportunity for intervention and health service provision. Every 
effort must be made to ensure that services are accessible, non-judgmental, accommodating and 
effective so that young people are encouraged to embrace the wider services that are available to 
them and that they are protected from infection and the social disintegration that can occur with 
prolonged drug misuse. 
5.2.3 Prevention services and opportunities 
It is crucial that young people do not encounter barriers to protecting themselves, such as parental 
permission, mandatory treatment, and statutory notification. Anything that drives them away from 
services increases their risk of harm. The statutory services may find this situation leaves them in 
an awkward position as there are constitutional restrictions on services that can be offered to 
minors. The policy of mandatory consultation with a psychiatrist appears to be preventing young 
users from availing of services. This compulsory visit changes the philosophy of a low threshold 
of entry to the needle exchange and identifies it much more with an official health board drug 
service. Anecdotal evidence suggests that young people see this as a deterrent and will refuse to 
come in the first place and not come back where this policy is in place. The policy may be a good 
one and in place for good reasons but if it is preventing young people from accessing sterile 
equipment with which to protect themselves then it needs to be reviewed. One city centre 
exchange is a non-statutory service that works in co-operation with the health board and 
participates in the data system of the needle exchange programme. The clinic workers 
interviewed indicated that this clinic was where many young people now attended as there were 
no conditions placed on attendance and the services offered. This organisation reports an increase 
in young injectors in its 1998 annual report (11). 
The increased risk of infection among recent onset injectors emphasises the importance of 
targeting preventive interventions early for them to be most effective. The potential for 
intervention and prevention in this young cohort has important public health implications. 
Prevention measures may not have initially been envisioned to be needed by such ‘a young 
population and may not be targeted enough. 
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Conclusions 
The information gained from this analysis of the needle exchange programme can be used to 
identify groups within the drug injecting community that may need prevention and service 
programmes targeted to their needs. Young injectors have specific needs that can be met by a 
service willing to address them. Attention should be paid to female injectors that may need 
services that take into account their patterns of behaviour and the presence of sexual partners and 
children in their lives.  Sexual risk and injecting risk, though related, need to be addressed as 
separate facets of high risk behaviour. Injectors’ ability and desire to engage in risk reduction can 
be facilitated by a prevention service with greater knowledge and understanding of injectors’ 
patterns of behaviour. 
Quantitative research such as this analysis by nature sacrifices depth of information for breadth of 
information. Qualitative research projects could fill in the gaps of understanding and knowledge 
with regards to this drug injecting group. Prevention initiatives will be greatly enhanced by a 
better understanding of the issues surrounding drug use, risk management and sexual 
relationships. Once-off research projects that enhance our understanding of issues can really make 
prevention strategies more effective. Effecting behaviour change is difficult but it is possible; 
with limited resources, targeted programmes that address the core issues for specific drug users in 
a community will be the most effective. A multidisciplinary approach is of particular importance. 
Prevention programmes, treatment and primary healthcare are essential. Of equal importance are 
social initiatives to expose the causes of the problem, including tackling social deprivation and 
marginalisation. 
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Recommendations 
1. Targeted prevention strategies for young and female injectors should be made available. 
2. An initiative should be launched to encourage risk awareness in young women. The 
importance of condom use as a preventive measure and the dangers of shared needle use 
with partners should be emphasised. 
3. The reasons for non-use of health services by young injectors should be determined. 
4. Qualitative research on young injectors should be undertaken to identify issues surrounding 
initiation into injecting drug use. 
5. Qualitative research should be initiated to explore the context of needle sharing and where 
and when this behaviour occurs. 
6. HTV and hepatitis testing should be linked to risk reduction counselling. 
7. HIV and Hepatitis prevalence in needle exchange population should be measured at regular 
intervals. 
8. The policy of mandatory consultation with a psychiatrist for young injectors should be 
reviewed. 
9. Feedback to clinic staff should be provided at regular intervals. 
10. Training should be provided to outreach staff on the data system. 
11. Information from the needle exchange programme should be made publicly available to 
complement the research and data reported in the Health Research Board Treated Drug 
Misuse in Ireland Report (7). 
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